CDNA
Caredx, Inc.
A precision medicine company focused on keeping transplanted organs healthy. CareDx makes non-invasive blood tests — AlloMap Heart and the AlloSure Kidney, Heart, and Lung panels — that monitor transplant recipients for early signs of rejection without a biopsy, along with HLA typing kits and AlloSeq gene-sequencing tools used to match donors and recipients. Its Ottr and MedActionPlan software help transplant teams track and manage patient care between visits.
CUSIP: 14167L1033 holders
Total Value
$209.22M
Total Shares
8.45M
Net Share Change
-4.09M
Activity
3 selling
Investor
Value
Shares
Weight
Change
